Aseptic meningitis associated with muromonab CD3 administration.
Sutton
J D
JD
Prioleau
M H
MH
Wordell
C J
CJ
Francos
G C
GC
D000293:Adolescent; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008581:Meningitis / Q000139:chemically induced*; D008582:Meningitis, Aseptic / Q000139:chemically induced* / Q000503:physiopathology; D016853:Muromonab-CD3
D000911:Antibodies, Monoclonal; D016853:Muromonab-CD3